• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

OncoGEMINI:用于从具有综合癌症注释的多个活检中研究肿瘤变体的软件。

OncoGEMINI: software for investigating tumor variants from multiple biopsies with integrated cancer annotations.

机构信息

Department of Human Genetics, University of Utah, Salt Lake City, UT, 84112, USA.

Utah Center for Genetic Discovery, University of Utah, Salt Lake City, UT, 84112, USA.

出版信息

Genome Med. 2021 Mar 26;13(1):46. doi: 10.1186/s13073-021-00854-6.

DOI:10.1186/s13073-021-00854-6
PMID:33771218
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7995589/
Abstract

BACKGROUND

DNA sequencing has unveiled extensive tumor heterogeneity in several different cancer types, with many exhibiting diverse subclonal populations. Identifying and tracing mutations throughout the expansion and progression of a tumor represents a significant challenge. Furthermore, prioritizing the subset of such mutations most likely to contribute to tumor evolution or that could serve as potential therapeutic targets represents an ongoing problem.

RESULTS

Here, we describe OncoGEMINI, a new tool designed for exploring the complex patterns and trajectory of somatic and inherited variation observed in heterogeneous tumors biopsied over the course of treatment. This is accomplished by creating a searchable database of variants that includes tumor sampling time points and allows for filtering methods that reflect specific changes in variant allele frequencies over time. Additionally, by incorporating existing annotations and resources that facilitate the interpretation of cancer mutations (e.g., CIViC, DGIdb), OncoGEMINI enables rapid searches for, and potential identification of, mutations that may be driving subclonal evolution.

CONCLUSIONS

By combining relevant genomic annotations alongside specific filtering tools, OncoGEMINI provides powerful and customizable approaches that enable the quick identification of individual tumor variants that meet specified criteria. It can be applied to a wide range of tumor-derived sequence data, but is especially designed for studies with multiple samples, including longitudinal datasets. It is available under an MIT license at github.com/fakedrtom/oncogemini .

摘要

背景

DNA 测序已经揭示了几种不同癌症类型中的广泛肿瘤异质性,其中许多表现出不同的亚克隆群体。在肿瘤的扩张和进展过程中识别和追踪突变是一项重大挑战。此外,优先考虑那些最有可能导致肿瘤进化或可能成为潜在治疗靶点的突变亚群也是一个持续存在的问题。

结果

在这里,我们描述了 OncoGEMINI,这是一种新的工具,用于探索在治疗过程中对异质肿瘤进行活检时观察到的体细胞和遗传变异的复杂模式和轨迹。这是通过创建一个可搜索的变体数据库来实现的,该数据库包括肿瘤采样时间点,并允许使用反映变体等位基因频率随时间变化的过滤方法。此外,通过整合有助于癌症突变解释的现有注释和资源(例如 CIViC、DGIdb),OncoGEMINI 能够快速搜索并可能识别可能驱动亚克隆进化的突变。

结论

通过将相关基因组注释与特定的过滤工具相结合,OncoGEMINI 提供了强大且可定制的方法,能够快速识别符合特定标准的个体肿瘤变体。它可以应用于广泛的肿瘤衍生序列数据,但特别设计用于具有多个样本的研究,包括纵向数据集。它在 MIT 许可证下可在 github.com/fakedrtom/oncogemini 获得。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a1/7995589/3d2b0d1faea3/13073_2021_854_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a1/7995589/315fb374538e/13073_2021_854_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a1/7995589/4a80502d9d14/13073_2021_854_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a1/7995589/3d2b0d1faea3/13073_2021_854_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a1/7995589/315fb374538e/13073_2021_854_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a1/7995589/4a80502d9d14/13073_2021_854_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a1/7995589/3d2b0d1faea3/13073_2021_854_Fig3_HTML.jpg

相似文献

1
OncoGEMINI: software for investigating tumor variants from multiple biopsies with integrated cancer annotations.OncoGEMINI:用于从具有综合癌症注释的多个活检中研究肿瘤变体的软件。
Genome Med. 2021 Mar 26;13(1):46. doi: 10.1186/s13073-021-00854-6.
2
Genome analysis and knowledge-driven variant interpretation with TGex.基因组分析和基于 TGex 的知识驱动的变异解释。
BMC Med Genomics. 2019 Dec 30;12(1):200. doi: 10.1186/s12920-019-0647-8.
3
VariantAlert: A web-based tool to notify updates in genetic variant annotations.变异警报:一个基于网络的工具,用于通知遗传变异注释的更新。
Hum Mutat. 2022 Dec;43(12):1808-1815. doi: 10.1002/humu.24495. Epub 2022 Nov 3.
4
MixClone: a mixture model for inferring tumor subclonal populations.MixClone:一种用于推断肿瘤亚克隆群体的混合模型。
BMC Genomics. 2015;16 Suppl 2(Suppl 2):S1. doi: 10.1186/1471-2164-16-S2-S1. Epub 2015 Jan 21.
5
Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes.用于使用单分子分子倒置探针识别和注释临床相关变异的开源CIViC注释管道
JCO Clin Cancer Inform. 2019 Oct;3:1-12. doi: 10.1200/CCI.19.00077.
6
FAVR (Filtering and Annotation of Variants that are Rare): methods to facilitate the analysis of rare germline genetic variants from massively parallel sequencing datasets.FAVR(稀有变体的过滤和注释):一种从大规模平行测序数据集中分析罕见种系遗传变异的方法。
BMC Bioinformatics. 2013 Feb 25;14:65. doi: 10.1186/1471-2105-14-65.
7
FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures.FIREVAT:使用与病因相关的突变特征在人类癌症样本中无伪影地发现可靠变异。
Genome Med. 2019 Dec 17;11(1):81. doi: 10.1186/s13073-019-0695-x.
8
Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants.变体解读癌症工具(VIC):一个用于评估体细胞变异临床影响的计算工具。
Genome Med. 2019 Aug 23;11(1):53. doi: 10.1186/s13073-019-0664-4.
9
Combining accurate tumor genome simulation with crowdsourcing to benchmark somatic structural variant detection.结合精确的肿瘤基因组模拟和众包基准测试体细胞结构变异检测。
Genome Biol. 2018 Nov 6;19(1):188. doi: 10.1186/s13059-018-1539-5.
10
Evaluating somatic tumor mutation detection without matched normal samples.评估无配对正常样本的体细胞肿瘤突变检测。
Hum Genomics. 2017 Sep 4;11(1):22. doi: 10.1186/s40246-017-0118-2.

引用本文的文献

1
Genomic landscape of hepatocellular carcinoma in Egyptian patients by whole exome sequencing.埃及患者肝癌的全外显子组测序基因组图谱。
BMC Med Genomics. 2024 Aug 9;17(1):202. doi: 10.1186/s12920-024-01965-w.
2
Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts.整合药物-基因相互作用数据库(DGIdb 4.0)与开放众包工作。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1144-D1151. doi: 10.1093/nar/gkaa1084.

本文引用的文献

1
Non-coding and Loss-of-Function Coding Variants in TET2 are Associated with Multiple Neurodegenerative Diseases.非编码和 TET2 功能丧失编码变异与多种神经退行性疾病相关。
Am J Hum Genet. 2020 May 7;106(5):632-645. doi: 10.1016/j.ajhg.2020.03.010. Epub 2020 Apr 23.
2
Exome sequencing of family trios from the National Birth Defects Prevention Study: Tapping into a rich resource of genetic and environmental data.家系三人组外显子组测序:挖掘丰富的遗传和环境数据资源。
Birth Defects Res. 2019 Dec 1;111(20):1618-1632. doi: 10.1002/bdr2.1554. Epub 2019 Jul 21.
3
Early activating somatic PIK3CA mutations promote ectopic muscle development and upper limb overgrowth.
早期激活的体细胞 PIK3CA 突变促进异位肌肉发育和上肢过度生长。
Clin Genet. 2019 Aug;96(2):118-125. doi: 10.1111/cge.13543. Epub 2019 May 9.
4
COSMIC: the Catalogue Of Somatic Mutations In Cancer.COSMIC:癌症体细胞突变目录。
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947. doi: 10.1093/nar/gky1015.
5
Strelka2: fast and accurate calling of germline and somatic variants.Strelka2:快速准确地调用种系和体细胞变异。
Nat Methods. 2018 Aug;15(8):591-594. doi: 10.1038/s41592-018-0051-x. Epub 2018 Jul 16.
6
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations.癌症基因组解读器注释肿瘤改变的生物学和临床相关性。
Genome Med. 2018 Mar 28;10(1):25. doi: 10.1186/s13073-018-0531-8.
7
Personal Cancer Genome Reporter: variant interpretation report for precision oncology.个人癌症基因组报告:精准肿瘤学的变异解释报告。
Bioinformatics. 2018 May 15;34(10):1778-1780. doi: 10.1093/bioinformatics/btx817.
8
DGIdb 3.0: a redesign and expansion of the drug-gene interaction database.DGIdb 3.0:药物-基因相互作用数据库的重新设计和扩展。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1068-D1073. doi: 10.1093/nar/gkx1143.
9
Combating subclonal evolution of resistant cancer phenotypes.对抗耐药肿瘤表型的亚克隆进化。
Nat Commun. 2017 Nov 1;8(1):1231. doi: 10.1038/s41467-017-01174-3.
10
OncoKB: A Precision Oncology Knowledge Base.OncoKB:一个精准肿瘤知识库。
JCO Precis Oncol. 2017 Jul;2017. doi: 10.1200/PO.17.00011. Epub 2017 May 16.